Messy Rollout Of Health Law Echoes Medicare Drug Expansion : Shots - Health News The history of the Medicare drug law, and Medicare itself, suggests that rough launches of health expansions don't necessarily signal a lasting failure. So, proponents say, even a misfire of the health exchanges wouldn't doom the federal overhaul.
NPR logo

Messy Rollout Of Health Law Echoes Medicare Drug Expansion

  • Download
  • <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript
Messy Rollout Of Health Law Echoes Medicare Drug Expansion

Messy Rollout Of Health Law Echoes Medicare Drug Expansion

  • Download
  • <iframe src="" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player">
  • Transcript


It's MORNING EDITION, from NPR News. I'm Renee Montagne.


And I'm David Greene. Good morning. The Affordable Care Act has endured plenty of criticism. Things really heated up this past week, though, following an announcement from the Obama administration that key parts of the healthcare law are being delayed. This was the House Budget Committee chairman, Republican Paul Ryan.

REPRESENTATIVE PAUL RYAN: This law is literally just unraveling before our eyes. I don't know how you can conclude that this is not a total fiasco.

GREENE: This is, actually, not the first time a major health law has gotten off to a rocky start. Not long ago, it was a Republican president pushing a Medicare prescription drug law facing criticism from Democrats. NPR's Julie Rovner looks back at that law and the lessons learned.

JULIE ROVNER, BYLINE: In the summer of 2005, as the Bush administration prepared for the rollout of the Medicare drug law, things didn't look so promising for that undertaking. Sabrina Corlette is a research professor at Georgetown University.

SABRINA CORLETTE: About this time in 2005, the percentage of people who had an unfavorable opinion of the law was actually higher than those who had a favorable opinion. So there was a lot of uncertainty and a lot of questions about whether this program was a good idea.

ROVNER: Corlette says many of the same complaints being made about the Affordable Care Act today were also made about the new Medicare program, which invited private insurance plans to compete to offer prescription drug coverage to seniors and the disabled.

CORLETTE: A lot of folks really questioned the design of the program. They thought it was gonna cost way too much. There were a lot of concerns about it.

ROVNER: Many of those concerns, of course, were coming from Democrats. They were infuriated that Republicans were getting credit for adding a drug benefit, known as Medicare Part D. The Democrats weren't anywhere near as vitriolic about the Medicare plan as Republicans have been about the health law, but there was still quite the partisan tenor to the complaints, remembers Mike Leavitt. He was Secretary of Health and Human Services at the time.

MIKE LEAVITT: There is always a political backdrop to the implementation of a controversial law. With Part D, clearly, the Democrats did not believe this would succeed, and I think in their heart didn't want it to succeed.

ROVNER: And you know how this time, Republicans have been critical of the Obama administration's efforts to promote the Affordable Care Act? In 2005, Democrats were outraged by the Bush administration's promotional efforts for the Medicare Law. Those mostly involved a nationwide bus tour that featured top administration officials, as well as representatives of private companies. Leavitt reflected on that tour at a recent session at the Brookings Institution.

LEAVITT: I went to 119 cities myself - I'm sorry, 98 cities and did 119 events. The bus travelled over 600,000 miles. We had 50,000 events that we had ultimately orchestrated.

ROVNER: Yet perhaps the most memorable part of the rollout of the Medicare drug law was when it first went live on New Years Day 2006. Things didn't go particularly well. Computers couldn't talk to each other properly. Seniors ended up on endless phone holds. It took several months to work out many of the kinks. Gary Cohen is overseeing the implementation of the health law for the Department of Health and Human Services this time. He said at that Brookings session he and his staff have learned a lot of important lessons from the Medicare drug law experience.

GARY COHEN: October 2nd, it's all hands on deck.

ROVNER: That's the day after the health exchanges open for people to start signing up.

COHEN: Be prepared for the fact that things aren't going to be absolutely perfect right out of the gate. And I think we're trying to communicate that, to make sure that people understand that, you know, this is big. It is complicated, but, you know, over the course of time, you know, we will get there, and we are mobilized to try to address whatever issues are going to come up.

ROVNER: Which is eventually what happened with the Medicare drug law, says Georgetown's Corlette.

CORLETTE: Eight years later, it's inconceivable that we wouldn't have a Medicare drug benefit. It's an enormously popular program, no matter what your political persuasion.

ROVNER: Which hardly guarantees a similar success for the health law. But the history of not just the Medicare drug law, but Medicare itself and other major federal programs have shown that less-than-smooth launches have not necessarily signaled a failure to follow. Julie Rovner, NPR News, Washington.

Copyright © 2013 NPR. All rights reserved. Visit our website terms of use and permissions pages at for further information.

NPR transcripts are created on a rush deadline by Verb8tm, Inc., an NPR contractor, and produced using a proprietary transcription process developed with NPR. This text may not be in its final form and may be updated or revised in the future. Accuracy and availability may vary. The authoritative record of NPR’s programming is the audio record.